down arrow

Neuland Labs.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE794A01010
  • NSEID: NEULANDLAB
  • BSEID: 524558
INR
11,690.80
790.75 (7.25%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 41.64 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Jubilant Pharmo
Cipla
Caplin Point Lab
Natco Pharma
Sun Pharma.Inds.
Sanofi India
Torrent Pharma
Neuland Labs.
Mankind Pharma
Sai Life
Why is Neuland Laboratories Ltd ?
1
Negative results in Dec 24
  • PBT LESS OI(Q) At Rs 68.07 cr has Fallen at -19.6 %
  • PAT(Q) At Rs 57.24 cr has Fallen at -13.3 %
2
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Apr-25 and has generated 6.2% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
3
With ROE of 18.9, it has a Very Expensive valuation with a 10 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 87.39%, its profits have fallen by -24.3%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Neuland Labs. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Neuland Labs.
89.19%
1.50
58.11%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.57%
EBIT Growth (5y)
39.39%
EBIT to Interest (avg)
16.85
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.97
Tax Ratio
24.89%
Dividend Payout Ratio
6.02%
Pledged Shares
0
Institutional Holding
33.34%
ROCE (avg)
17.05%
ROE (avg)
13.21%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
58
Industry P/E
33
Price to Book Value
10.02
EV to EBIT
44.28
EV to EBITDA
36.68
EV to Capital Employed
10.58
EV to Sales
9.07
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
26.61%
ROE (Latest)
18.93%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 5.00 times

EPS(Q)

Highest at Rs 78.75

-9What is not working for the Company
PBT LESS OI(Q)

At Rs 68.07 cr has Fallen at -19.6 %

PAT(Q)

At Rs 57.24 cr has Fallen at -13.3 %

Loading Valuation Snapshot...
Here's what is working for Neuland Labs.
Earnings per Share (EPS) - Quarterly
Highest at Rs 78.75
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debtors Turnover Ratio- Half Yearly
Highest at 5.00 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Neuland Labs.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 68.07 cr has Fallen at -19.6 %
over average PBT of the previous four quarters of Rs 84.68 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 57.24 cr has Fallen at -13.3 %
over average PAT of the previous four quarters of Rs 66.03 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)